Viral Shah

Dr. Shah is a Professor of Medicine, Division of Endocrinology & Metabolism and Director of Diabetes Clinical Research at the Indiana University Center for Diabetes and Metabolic Diseases. 

His research is focused on the use of diabetes technologies and adjunctive therapies in people with type 1 diabetes (T1D) to improve glycemic outcomes and reduce diabetes related complications. Dr. Shah has served as principal investigator for numerous clinical trials evaluating diabetes technologies and therapeutics and has contributed to multiple landmark studies that led to FDA approval of therapies and significantly advanced T1D management.

Dr. Shah has held numerous national leadership roles, including serving on the Steering Committee of the T1D Exchange Clinic Registry (2016–2017) and the Scientific Sessions Planning Committee of the American Diabetes Association (2023–2024) and Chair of the Diabetes Technology Interest Group at the American Diabetes Association (2023-2025).

Dr. Shah has received several prestigious honors, including the AACE Rising Star in Endocrinology Award (2021), the ADA Diabetes Technology Interest Group Award (2022), the Diabetes Technology Society Leadership Award (2023), and the Mary Tyler Moore and S. Robert Levine, MD Excellence in Clinical Research Award from Breakthrough T1D (2024).

Dr. Shah is the author of Clinical Decision Algorithms in Diabetes, one of the best-selling books published by the American Diabetes Association. He serves on the Editorial Board for many Journals and is well published with over 250 research publications.